Evaluation of propofol sparing effect of intravenous lignocaine in patients undergoing daycare upper Gastro Intestinal endoscopic procedures
Not yet recruiting
- Conditions
- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere, (2) ICD-10 Condition: O||Medical and Surgical, (3) ICD-10 Condition: K831||Obstruction of bile duct,
- Registration Number
- CTRI/2020/10/028697
- Lead Sponsor
- Indira Gandhi Institute of Medical Sciences
- Brief Summary
Sedation protocol employed during endoscopic procedures might hinder early recovery and discharge from hospital.We intend to observe whether addition of lignocaine to sedation protocol help early discharge from hospital.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patients of age 18-65 years ASA Grade-I & II Undergoing day care upper G.I. endoscopic procedures under sedation.
Exclusion Criteria
Patient refusal ASA Grade-III & IV Unstable hemodynamic status Mental disorders, such as schizophrenia and psychosis on long-term psychotropic drugs Hyperalgesia or refractory cancer pain Allergic to study agent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Total amount of propofol administered during the procedure After procedure 2.Total supplemental amount of propofol after induction and After procedure 3.Number of boluses of supplemental propofol After procedure
- Secondary Outcome Measures
Name Time Method Recovery scores VAS score
Trial Locations
- Locations (1)
Indira Gandhi Institute of Medical Sciences
🇮🇳Patna, BIHAR, India
Indira Gandhi Institute of Medical Sciences🇮🇳Patna, BIHAR, IndiaMumtaz HussainPrincipal investigator9973152076drhussain72@yahoo.co.in